PAXLOVID
Date
March 2022
Description
Paxlovid (also known as ritonavir-boosted nirmatrelvir) are oral antiviral pills used for the treatment of mild to moderate COVID-19 disease. This box was prescribed under a US Food and Drug Administration (FDA) emergency use authorization (EUA) in March
Source
US Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), Pfizer BioNTech
Citation
“PAXLOVID,” The Global Health Chronicles, accessed December 1, 2023, https://globalhealthchronicles.org/items/show/8564.